3-n-methylspiperone has been researched along with fluorobenzenes in 1 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (fluorobenzenes) | Trials (fluorobenzenes) | Recent Studies (post-2010) (fluorobenzenes) |
---|---|---|---|---|---|
155 | 6 | 7 | 3,032 | 581 | 1,214 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dannals, RF; GrĂ¼nder, G; Howard, DR; Offord, SJ; Ravert, HT; Salzmann, JK; Szymanski, S; Wilson, PD; Wong, DF; Yokoi, F | 1 |
1 other study(ies) available for 3-n-methylspiperone and fluorobenzenes
Article | Year |
---|---|
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Male; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Spiperone; Time Factors; Tomography, Emission-Computed | 1997 |